We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





SeraCare Life Sciences Promotes New AccuSpan Panel at Lab Expo

By LabMedica International staff writers
Posted on 31 Jul 2018
SeraCare Life Sciences (Milford, MA, USA) promoted its new AccuSpan HCV RNA Linearity Panel at the 70th AACC Annual Scientific Meeting and Clinical Lab Expo held in Chicago, USA from July 29 - August 2.

SeraCare is a leading partner and supplier of diagnostic quality controls, biological materials, and reagents to in vitro diagnostics developers, clinical laboratories, and life science researchers worldwide. More...
The company supports the diagnostic testing industry with biological materials to develop, validate, and challenge today's most trusted serology and molecular infectious disease assays. With recent rapid advances in clinical genomics and precision diagnostics, SeraCare has developed a leading portfolio of highly flexible, patient-like reference materials and lab QC programs to support advanced diagnostic applications such as next-generation sequencing and digital PCR.

At AACC 2018, SeraCare promoted its new AccuSpan HCV RNA Linearity Panel, a safe, non-infectious panel that is compatible with leading PCR-based applications and features eight members in K3EDTA plasma. The eight-member panel is made from serial dilutions of high titer recombinant Hepatitis C virus (genotype 1b) with established reactivity for HCV RNA and one negative member. The panel consists of seven members representing serial log dilutions of AccuPlex recombinant HCV in negative diluent and one negative member prepared from the diluent. The diluent was prepared from pooled K3EDTA plasma that was filtered through a 0.2 micron filter with sodium azide (0.09%) added as a preservative.

The panel can be used for monitoring HCV RNA recovery at defined intervals, identifying consistency over a linear range, verifying lot changes, performing linearity studies, or whenever there are indications of possible assay deterioration.

Related Links:
SeraCare Life Sciences


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
New
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.